Glycotope

Developer of Glyco-optimized antibodies and provider of contract research and manufacturing services.

placeBerlin, Berlin, Germany calendar_todayFounded 2001 groups116 employees language glycotope.com

Registered entities

Investor mix

10 investors on record; lead investors include Eckert Life Science Accelerator, Octapharma.

Investor typeCountShare
Venture capital110%
Other / undisclosed990%
Coming soon